{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:52:15Z","timestamp":1788054735808,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jhep.2011.09.014","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T02:03:07Z","timestamp":1321063387000},"page":"626-631","source":"Crossref","is-referenced-by-count":33,"title":["Regulatory T cells suppress sickness behaviour development without altering liver injury in cholestatic mice"],"prefix":"10.1016","volume":"56","author":[{"given":"Kimchi","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"D\u2019Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Urbanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2011.09.014_b0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrgastro.2010.62","article-title":"Fatigue in primary biliary cirrhosis","volume":"7","author":"Abbas","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2011.09.014_b0010","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.23683","article-title":"The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice","volume":"52","author":"Al-Harthy","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2011.09.014_b0020","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.1840150626","article-title":"Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice","volume":"15","author":"Bemelmans","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/00365520410003434","article-title":"Fatigue in patients with primary sclerosing cholangitis","volume":"39","author":"Bjornsson","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.09.014_b0030","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.4049\/jimmunol.176.12.7189","article-title":"Biliary obstruction selectively expands and activates liver myeloid dendritic cells","volume":"176","author":"Bleier","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0031-9384(00)00269-9","article-title":"Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice","volume":"70","author":"Bluthe","year":"2000","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jhep.2011.09.014_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.apnu.2009.04.010","article-title":"Predictors of mental health, subjective burden, and rewards in family caregivers of patients with chronic liver disease","volume":"24","author":"Bolden","year":"2006","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.jhep.2011.09.014_b0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/gast.2002.31878","article-title":"Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats","volume":"122","author":"Burak","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.09.014_b0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2011.09.014_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biopsych.2004.10.031","article-title":"Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635","volume":"57","author":"Cleare","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jhep.2011.09.014_b0065","first-page":"S11","article-title":"Interleukin-6 \u2013 a key mediator of systemic and local symptoms in rheumatoid arthritis","volume":"65","author":"Cronstein","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.jhep.2011.09.014_b0070","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","article-title":"Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation","volume":"29","author":"D\u2019Mello","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jhep.2011.09.014_b0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jhep.2011.09.014_b0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jhep.2011.09.014_b0085","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.09.014_b0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbi.2010.11.005","article-title":"Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: Brain substrates for fatigue?","volume":"25","author":"Gaykema","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jhep.2011.09.014_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2004.06.076","article-title":"Bacterial endotoxin induces STAT3 activation in the mouse brain","volume":"1023","author":"Hosoi","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.jhep.2011.09.014_b0100","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.0507191102","article-title":"Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness","volume":"102","author":"Johnson","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2011.09.014_b0105","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2010.05.026","article-title":"The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up","volume":"53","author":"Jones","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.09.014_b0110","first-page":"1613","article-title":"Serum interleukin-6 levels in patients with biliary obstruction","volume":"46","author":"Kimura","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2011.09.014_b0115","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI119846","article-title":"Pathways and mechanisms for cytokine signaling of the central nervous system","volume":"100","author":"Licinio","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2011.09.014_b0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","article-title":"The global impact of hepatic fibrosis and end-stage liver disease","volume":"12","author":"Lim","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2011.09.014_b0125","first-page":"113","article-title":"Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis","volume":"21","author":"Martinez","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jhep.2010.05.036","article-title":"Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms","volume":"53","author":"McDonald","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.09.014_b0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brainres.2004.02.063","article-title":"Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study","volume":"1009","author":"Menon","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.jhep.2011.09.014_b0140","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1460-9568.2008.06470.x","article-title":"Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice","volume":"28","author":"Mingam","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jhep.2011.09.014_b0145","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1023\/A:1020511002025","article-title":"Cytokine profile in the liver of primary biliary cirrhosis","volume":"19","author":"Nagano","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0150","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2005.12.012","article-title":"Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure","volume":"44","author":"Newton","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2011.09.014_b0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2982.2007.01016.x","article-title":"Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats","volume":"20","author":"Nguyen","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jhep.2011.09.014_b0160","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1248\/bpb.30.2001","article-title":"Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases","volume":"30","author":"Ohsugi","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jhep.2011.09.014_b0165","first-page":"233","article-title":"Anti-TNF therapy in inflammatory bowel diseases: a huge review","volume":"56","author":"Peyrin-Biroulet","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.jhep.2011.09.014_b0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/CRIAI:28:2:147","article-title":"Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy","volume":"28","author":"Pusl","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0175","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2011.09.014_b0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.21850","article-title":"Selective contribution of interleukin-6 and leptin to brain inflammatory signals induced by systemic LPS injection in mice","volume":"511","author":"Rummel","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jhep.2011.09.014_b0185","doi-asserted-by":"crossref","first-page":"R1316","DOI":"10.1152\/ajpregu.00301.2006","article-title":"Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain","volume":"291","author":"Rummel","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jhep.2011.09.014_b0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1164\/rccm.200303-311OC","article-title":"Cholestatic interleukin-6-deficient mice succumb to endotoxin-induced liver injury and pulmonary inflammation","volume":"169","author":"Sewnath","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2011.09.014_b0200","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.3748\/wjg.14.3338","article-title":"Clinical features and management of primary sclerosing cholangitis","volume":"14","author":"Silveira","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.09.014_b0205","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2567.2008.02813.x","article-title":"Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target","volume":"124","author":"Sojka","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jhep.2011.09.014_b0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2006\/624832","article-title":"Fatigue in liver disease: pathophysiology and clinical management","volume":"20","author":"Swain","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2011.09.014_b0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510280102","article-title":"Chronic cholestasis in rats induces anhedonia and a loss of social interest","volume":"28","author":"Swain","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.510250206","article-title":"Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment","volume":"25","author":"Swain","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0225","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/hep.20698","article-title":"A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue","volume":"41","author":"Theal","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.09.014_b0230","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2011.09.014_b0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2011.09.014_b0240","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2008.10.027","article-title":"Invariant natural killer T cells suppress the neutrophil inflammatory response in a mouse model of cholestatic liver damage","volume":"136","author":"Wintermeyer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.09.014_b0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11373-004-8170-z","article-title":"ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells","volume":"12","author":"Wung","year":"2005","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.jhep.2011.09.014_b0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1098-2825(1998)12:2<77::AID-JCLA1>3.0.CO;2-G","article-title":"Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults","volume":"12","author":"Yamashiki","year":"1998","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jhep.2011.09.014_b0255","doi-asserted-by":"crossref","first-page":"R403","DOI":"10.1152\/ajpregu.00395.2009","article-title":"MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus","volume":"298","author":"Yamawaki","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jhep.2011.09.014_b0260","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00011-008-7234-3","article-title":"Regulatory CD4+CD25+ T cells and macrophages: communication between two regulators of effector T cells","volume":"57","author":"Zhen","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jhep.2011.09.014_b0265","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1517\/14728222.12.3.313","article-title":"CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases","volume":"12","author":"Zheng","year":"2008","journal-title":"Expert Opin Ther Targets"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811007768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811007768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T12:36:59Z","timestamp":1560947819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827811007768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0168827811007768"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2011.09.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}